Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedSci Healthcare HoldingsHKSE:02415 -0.65%75 3-Year ROIIC % is 78.11 as of Dec. 2025, which is at its 10-year median of 78.11. GuruFocus rates HKSE:02415 with a GF Score™ of 75/100 and a GF Value™ of HK$1.43 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 618 Healthcare Providers & Services companies, MedSci Healthcare Holdings ranks better than 87.7% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
MedSci Healthcare Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 78.11%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for MedSci Healthcare Holdings's 3-Year ROIIC % or its related term are showing as below:
HKSE:02415's 3-Year ROIIC % is ranked better than 87.7% of 618
companies
in the Healthcare Providers & Services industry
Industry Median: 3.64
vs HKSE:02415: 78.11
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
MedSci Healthcare Holdings 3-Year ROIIC % Related Terms
MedSci Healthcare Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02415 vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, MedSci Healthcare Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedSci Healthcare Holdings 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where MedSci Healthcare Holdings's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 31.1476048 (Dec. 2025) - 7.178 (Dec. 2022) )
/
( 212.289 (Dec. 2025) - 181.603 (Dec. 2022) )
=
23.9696048
/
30.686
=
78.11%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
MedSci Healthcare Holdings (HKSE:02415) has a 3-Year ROIIC % of 78.11 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on MedSci Healthcare Holdings and its competitors. This is near median its historical median of 78.11. According to the industry distribution chart, MedSci Healthcare Holdings ranks #76 out of 618 companies in the Healthcare Providers & Services industry, placing it in the top 12.3%.
Is MedSci Healthcare Holdings' 3-Year ROIIC % too high?
MedSci Healthcare Holdings' current 3-Year ROIIC % of 78.11 is near median its 10-year median of 78.11. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.64. MedSci Healthcare Holdings' value of 78.11 is 2045.9% above this industry median. Based on the distribution chart, MedSci Healthcare Holdings ranks #76 out of 618 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MedSci Healthcare Holdings has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedSci Healthcare Holdings' 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedSci Healthcare Holdings ranks #76 out of 618 companies for 3-Year ROIIC %. This places MedSci Healthcare Holdings in the top 12% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.64. MedSci Healthcare Holdings' value of 78.11 is 2045.9% above this benchmark. While the company's 10-year median is 78.11 vs. the industry median of 3.64, MedSci Healthcare Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.64, based on 618 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedSci Healthcare Holdings's current 3-Year ROIIC % of 78.11 is 2045.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on MedSci Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedSci Healthcare Holdings's current 3-Year ROIIC % is 78.11, which is near median its own 10-year median of 78.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedSci Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, MedSci Healthcare Holdings (HKSE:02415) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.43, compared to a current price of HK$0.76 — trading 46.9% below its estimated fair value. The current 3-Year ROIIC % is 78.11, which is near median its 10-year median of 78.11 and 2045.9% above the Healthcare Providers & Services industry median of 3.64. MedSci Healthcare Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For MedSci Healthcare Holdings (HKSE:02415), the current 3-Year ROIIC % is 78.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedSci Healthcare Holdings (HKSE:02415) Overvalued in 2026?
Based on GuruFocus' analysis, MedSci Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.76 is trading 46.9% below its estimated GF Value™ of HK$1.43.
GuruFocus considers MedSci Healthcare Holdings to be Possible Value Trap.
Key valuation signals for HKSE:02415:
3-Year ROIIC %: 78.11 (near median its 10-year median of 78.11)
GF Value™: HK$1.43 vs. price of HK$0.76 (46.9% below fair value)
Industry Position: 2045.9% above the Healthcare Providers & Services median (#76 of 618)
No single metric tells the full story. See the HKSE:02415 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
75GF Score
Get the complete analysis for HKSE:02415
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02415 has been successfully added to your 
